Treatment of HIV-1 infection with combinations of highly active antiretroviral agents (HAART) has achieved remarkable suppression of viral replication in many individuals whereas others have rapidly become resistant to treatment. Compared to adults, children generally develop higher as well as more sustained HIV-1 loads early in infection, which may predispose them to rapid development of disease and drug resistance. Understanding viral evolution in children during HAART will aid in tailoring treatment regimens for optimal efficacy. Hence, the Principal Investigator proposed to (1) define the kinetics of viral and T cell turnover in HIV1-infected children and, specifically, determine if the high viral loads found in children are the result of increased viral production or impaired clearance; (2) determine the rate of viral evolution in children before and after HAART, through an analysis of viral env and pro, as well as markers of antiviral resistance in pol; (3) define the mode of viral recombination, a process that would allow the combination of important genetic traits with minimal cycles of viral replication compared to that required for the progressive selection for additive mutations in the development of HIV-1 resistance to HAART as the continued evolution of provirus in children with plasma HIV-1 RNA levels below the level of detection would indicate the persistence of partially suppressed replication competent virus, whereas the lack of evolution would be consistent with complete suppression of viral replication] understanding the mechanisms of the development of viral resistance is critical to optimizing HIV-1 treatment strategies; and (4) to improve understanding of the driving forces of viral evolution in vivo, and because differences in tissue penetration and intracellular metabolism of antivirals may allow the evolution of resistant viruses within certain cell types, to determine whether resistance to HAART is associated with changes in virus cell tropism and co-receptor use.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Research Project (R01)
Project #
5R01HD036184-04
Application #
6343213
Study Section
AIDS and Related Research Study Section 2 (ARRB)
Program Officer
Nugent, Robert
Project Start
1998-01-01
Project End
2002-12-31
Budget Start
2001-01-01
Budget End
2001-12-31
Support Year
4
Fiscal Year
2001
Total Cost
$397,417
Indirect Cost
Name
Seattle Children's Hospital
Department
Type
DUNS #
048682157
City
Seattle
State
WA
Country
United States
Zip Code
98105
Wagner, Thor A; Frenkel, Lisa M (2008) Potential limitation of CCR5 antagonists: drug resistance more often linked to CXCR4-utilizing than to CCR5-utilizing HIV-1. AIDS 22:2393-5
Holte, Sarah E; Melvin, Ann J; Mullins, James I et al. (2006) Density-dependent decay in HIV-1 dynamics. J Acquir Immune Defic Syndr 41:266-76
Li, Chung-Chen; Seidel, Kristy D; Coombs, Robert W et al. (2005) Detection and quantification of human immunodeficiency virus type 1 p24 antigen in dried whole blood and plasma on filter paper stored under various conditions. J Clin Microbiol 43:3901-5
Tobin, Nicole H; Learn, Gerald H; Holte, Sarah E et al. (2005) Evidence that low-level viremias during effective highly active antiretroviral therapy result from two processes: expression of archival virus and replication of virus. J Virol 79:9625-34
Ellis, Giovanina M; Mahalanabis, Madhumita; Beck, Ingrid A et al. (2004) Comparison of oligonucleotide ligation assay and consensus sequencing for detection of drug-resistant mutants of human immunodeficiency virus type 1 in peripheral blood mononuclear cells and plasma. J Clin Microbiol 42:3670-4
Beck, Ingrid A; Mahalanabis, Madhumita; Pepper, Gregory et al. (2002) Rapid and sensitive oligonucleotide ligation assay for detection of mutations in human immunodeficiency virus type 1 associated with high-level resistance to protease inhibitors. J Clin Microbiol 40:1413-9
Naugler, Willscott E; Yong, Florence H; Carey, Vincent J et al. (2002) T69D/N pol mutation, human immunodeficiency virus type 1 RNA levels, and syncytium-inducing phenotype are associated with CD4 cell depletion during didanosine therapy. J Infect Dis 185:448-55
Melvin, Ann J; Lewis, Paul F; Mohan, Kathleen M et al. (2002) Efficacy and toxicity of antiretroviral therapy using 4 or more agents: application of a strategy for antiretroviral management in human immunodeficiency virus-infected children. Arch Pediatr Adolesc Med 156:568-73
Melvin, A J; Rodrigo, A G; Mohan, K M et al. (1999) HIV-1 dynamics in children. J Acquir Immune Defic Syndr Hum Retrovirol 20:468-73